Table 1.
Country | Focus | Treatment Approach | Rounds >85% Through 2016 | Number of Communities | Population at Risk | Population No Longer at Risk | Population Eligible for Treatment | Status of Transmission | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Colombia | Lopez de Micay | 2×/year | 20 | 1 | 1366 | Eliminated in 2010 | |||||
Ecuador | Esmeraldas | 2×/year | 25 | 119 | 25,863 | Eliminated in 2012 | |||||
Mexico | North Chiapas | 2×/year | 17 | 13 | 7125 | Eliminated in 2010 | |||||
Oaxaca | 2×/year | 18 | 98 | 44,919 | Eliminated in 2011 | ||||||
South Chiapas | 2×/year | 25 | 396 | 83,218 | Eliminated in 2014 | ||||||
4×/year | 35 | 163 | 34,607 | ||||||||
Focus total | 559 | 117 825 | |||||||||
Guatemala | Escuintla | 2×/year | 13 | 117 | 62,590 | Eliminated in 2010 | |||||
Santa Rosa | 2×/year | 16 | 37 | 12,208 | Eliminated in 2010 | ||||||
Huehuetenango | 2×/year | 17 | 43 | 30,239 | Eliminated in 2011 | ||||||
Central | 2×/year | 22 | 321 | 126 430 | Eliminated in 2014 | ||||||
Venezuela | North central | 2×/year | 17 | 45 | 14,385 | Eliminated in 2013 | |||||
Northeast | 2×/year | 20 | 330 | 73,212 | Eliminated in 2017 | ||||||
4×/year | 9 | 135 | 22,355 | ||||||||
Focus total | 465 | 95,567 | |||||||||
South | 2×/year | 16 | 66 | 4248 | 3744 | Ongoing | |||||
4×/year | 9 | 236 | 10,838 | 9273 | |||||||
Focus total | 302 | 15,086 | 13,017 | ||||||||
Brazil | Amazonas | 2×/year | 26 | 117 | 7209 | 5954 | Ongoing | ||||
4×/year | 13 | 122 | 8266 | 6634 | |||||||
Focus total | 239 | 15,475 | 12,588 | ||||||||
Regional total | 2359 | 30,561 | 538 517 | 25,605 |
Notes: Reprinted from Sauerbrey M, Lindsay JR, Richards FO Jr. Progress toward elimination of onchocerciasis in the Americas. Int Health. 2018;10:i71–i78, by permission of Oxford University Press.12